Healthineer’s Q2 was characterised by Imaging’s continued strong performance, whereas Advanced Therapies’ strong top-line development did not emerge at the profitability level. Despite being under special supervision of the CEO, Diagnostic’s performance was slightly held back. The reported figures were above our expectations and beat consensus (sales: €3,565m; adjusted EBIT: €563m).
05 May 2020
Imaging still pushing the accelerator pedal
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Imaging still pushing the accelerator pedal
Siemens Aktiengesellschaft (SIE:WBO) | 0 0 0.4% | Mkt Cap: 93,908m
- Published:
05 May 2020 -
Author:
Martin Schnee -
Pages:
3
Healthineer’s Q2 was characterised by Imaging’s continued strong performance, whereas Advanced Therapies’ strong top-line development did not emerge at the profitability level. Despite being under special supervision of the CEO, Diagnostic’s performance was slightly held back. The reported figures were above our expectations and beat consensus (sales: €3,565m; adjusted EBIT: €563m).